Concepedia

Ketki Dhamnaskar

KD

Statistics

Publications

3

Citations

88

H-Index

3

Active since

2014

Affiliations

UCB Pharma (United States)(Current)

Ketki Dhamnaskar is an author at UCB Pharma (United States) specializing in medicine, pharmacology, and complement system.

Publications per year

2014–2023

3

Publications

3

Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation

Guoqing Tang, Yalan Tang, Ketki Dhamnaskar et al. · Frontiers in Immunology · 2023 · 43 citations · Full text

, , +15

Preclinical Evaluation of RA101495, a Potent Cyclic Peptide Inhibitor of C5 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Alonso Ricardo, Michelle Arata, Steven J. DeMarco et al. · Blood · 2015 · 34 citations

, , +6

Development of RA101348, a Potent Cyclic Peptide Inhibitor of C5 for Complement-Mediated Diseases

Alonso Ricardo, Michelle Arata, Steven J. DeMarco et al. · Blood · 2014 · 11 citations

, , +14

1–3 of 3